PATH Stock Recent News
PATH LATEST HEADLINES
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic automation, boasts a large ARR base, and has high gross margins, making it a strong AI investment. The stock is one of few software companies to trade at just ~2x revenue and ~10x FCF.
Five high-quality AI stocks are currently available on the dip at attractive valuations. These are ANET, PATH, JBL, BWXT and FIVN.
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UiPath, Zoom Communication, NVIDIA and Microsoft are leading the charge in transforming industries with agentic AI advancements in 2025.
With PATH stock having corrected significantly, we assess its current status to decide on the best strategy for the future.
Is artificial intelligence a bubble? That's the trillion-dollar question.
NEW YORK--(BUSINESS WIRE)--UiPath announced UiPath Test Cloud, a new approach to software testing that uses AI to amplify tester productivity across the testing lifecycle.
Byrna, LiveRamp, Dave, Smiths and UiPath are included in this Analyst Blog.
In today's video, I discuss an artificial intelligence stock focused on agentic solutions, its business strategy, growth opportunities, potential risks, and whether investors should not ignore this AI stock.
UiPath's ARR is set to hit $1.816B in FY26 (+9% YoY), driven by 98% gross and 110% net retention. Cloud ARR surged past $975M (+50% YoY) as enterprise adoption of AI-driven automation accelerates. Profitability improved with a 32% non-GAAP margin, $328M free cash flow, and $1.7B cash (zero debt).